Richard Daniell, Executive VP, European Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD (TEVA), sold 144,018 shares at $9.93 ($1.4M) on 2023-03-06, disclosed to the SEC on 2023-03-08.
Seasonal sale ($1.4M) by Executive VP, European Commercial — this insider has traded TEVA in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.93 | 18,002 | $179K | 13.0% |
| 2 | $9.93 | 18,002 | $179K | 13.0% |
| 3 | $9.43 | 54,007 | $509K | 37.0% |
| 4 | $9.43 | 54,007 | $509K | 37.0% |
| Total | $9.55 avg | 144,018 | $1.4M | 100% |
| Filing → |
| TEVA | SELL | 2026-03-06 | $6.0M | — | Filing → |
| TEVA | SELL | 2026-03-05 | $8.3M | — | Filing → |
| TEVA | SELL | 2025-12-11 | $6.6M | — | Filing → |